Daraprim
Daraprim - Basic Information
- GN: Pyrimethamine
- Con: Malaria
- Cla: information not available
Indication of Daraprim:
Used for the treatment of acquired and congenital toxoplasmosisAction of Daraprim:
Pharmacology.Pyrimethamine disrupts protozoal (e.g. toxoplasmosis) cell function.Pharmacokinetics.Peak plasma levels are achieved 2-4 hours after oral administration. Half life is approximately 90 hours.Dose Advice of Daraprim:
Adults, Children > 6 years.Daraprim: 2 tablets initially, then 1 tablet daily. (Coadminister Sulfadiazine 150 mg/kg/day)Children.2-6 years: 1 tablet initially, thenCon: Malaria